Showing results (831-840 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|January 1, 1992
Risperidone: clinical development: north American resultsS R MarderClinical Neuropharmacology|February 1, 1992
Parkinsonism associated with calcium channel blockers: a prospective follow-up studyP J García-Ruiz, J García de Yébenes, F J Jiménez-Jiménez, et al.Clinical Neuropharmacology|October 1, 1992
Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeysS Kuno, E Mizuta, J Nishida, et al.Clinical Neuropharmacology|January 1, 1992
Conditioned release of neurotransmitters as measured by microdialysisB G Hoebel, G P Mark, H L WestClinical Neuropharmacology|October 1, 1992
GABA-active steroids: endogenous modulators of GABA-gated chloride ion conductanceS I Deutsch, J Mastropaolo, A HitriClinical Neuropharmacology|January 1, 1984
Simultaneous presence of estrogen receptors and gonadotropin-releasing hormone in the hypothalamus and of estrogen receptors and follicle-stimulating hormone in the pituitary of the fetal guinea pigJ Tardy, J R PasqualiniClinical Neuropharmacology|January 1, 1984
A double-blind trial of clonazepam in benign essential tremorC Thompson, A Lang, J D Parkes, et al.Clinical Neuropharmacology|February 28, 2008
Effects of nebicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity, and motor fluctuations in patients with Parkinson diseaseJoaquim J Ferreira, Luis Almeida, Luis Cunha, et al.Clinical Neuropharmacology|October 3, 2007
Gambling and increased sexual desire with dopaminergic medications in restless legs syndromeErika D Driver-Dunckley, Brie N Noble, Joseph G Hentz, et al.Clinical Neuropharmacology|June 1, 1990
Chronic treatment with talipexole dihydrochloride on abnormal involuntary movement in humansT Nishikawa, S Yamada, A Tsuda, et al.Pageof 236